comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 18:24:09 - browse：3423

Adobe

The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan, which led to the health insurance company in California losing hundreds of millions of dollars in bonuses from the government, a judge ruled Monday.

The decision will lead to more than $250 million funneling back into SCAN, which covers 270,000 Medicare Advantage enrollees. And it opens the door for other Medicare Advantage plans to potentially recoup huge sums of taxpayer-funded bonuses — even though many independent experts believe the quality rating system is flawed and doesn’t appropriately gauge quality of care for older adults and people with disabilities.

The Centers for Medicare and Medicaid Services, the federal agency that oversees all Medicare programs, said it does not comment on litigation. In an interview, SCAN CEO Sachin Jain told STAT that if the company had not gotten its expected bonus money, it would have had to shave benefits and reduce what it pays hospitals and doctors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： How a key Senate committee is planning to regulate PBMs

knowledge

WSS

Medtronic CEO on promising devices for diabetes, hypertension

My chronic pain journey would have been easier knowing 5 things % STAT

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Sophia Smith scores twice for US in in 3

Clinic falsely told dozens they had Alzheimer's, suits say

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

leisure time

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

hotspot

Virginia high school admissions case could be legal follow

Malaysia cuts short music fest after British band slams anti

Psychedelics group wrestles with new pharma identity

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Walensky prepares to leave CDC — and Congress — behind

Inside the culture of fear in the White House science office of Eric Lander

Trump demands the U.S. pay no more for drugs than other countries … again

Eli Lilly to pay $200M for Beam’s stake in gene

Cancer drug shortages should be causing more outrage

First Opinion Podcast: How to protect health care in times of war

focus

Readout Newsletter: New research from Sanofi, Regeneron, etc.

FDA approves first blood sugar monitor without finger pricks

Novartis develops a rapidly manufactured CAR

Traditional Chinese medicine benefits explored in new JAMA study

Telehealth options flood the market as retailers push virtual care

Where does female orgasm come from? Scientists think they know

focus

explore

knowledge

focus